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SNARE proteins play a central role in the process of intracellular membrane fusion. Indeed, the interaction of SNAREs present on two
opposing membranes is generally believed to provide the driving force to initiate membrane fusion. Eukaryotic cells express a large number
of SNARE isoforms, and the function of individual SNAREs is required for specific intracellular fusion events. Exocytosis, the fusion of
secretory vesicles with the plasma membrane, employs the proteins syntaxin and SNAP-25 as plasma membrane SNAREs. As a result,
exocytosis is dependent upon the targeting of these proteins to the plasma membrane; however, the mechanisms that underlie trafficking of
exocytic syntaxin and SNAP-25 proteins to the cell surface are poorly understood. The intracellular trafficking itinerary of these proteins is
particularly intriguing as syntaxins are tail-anchored (or Type IV) membrane proteins, whereas SNAP-25 is anchored to membranes via a
central palmitoylated domain—there is no common consensus for the trafficking of such proteins within the cell. In this review, we discuss
the plasma membrane targeting of these essential exocytic SNARE proteins.
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Intracellular membrane fusion is essential for numerous
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membrane fusion depends upon the coordinated actions of
a wide range of cellular proteins, and the targeting of these
proteins to specific cellular compartments. The fusion of
intracellular vesicles with the plasma membrane occurs in a
process called exocytosis. This membrane fusion pathway is
essential for the targeting of newly synthesized proteins and
lipids to the plasma membrane, and also regulates the
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ized form of exocytosis is ‘regulated exocytosis’; in this
pathway, membrane fusion requires a specific stimulus, in
most cases an increase in intracellular calcium concentra-
tion. Regulated exocytosis underlies the controlled release
of numerous physiologically important molecules, including
neurotransmitters, catecholamines, and insulin.
Central to the process of membrane fusion are SNARE
proteins, which are localized to various intracellular organ-
elles and membranes [1]. Specific SNAREs present on two
opposing membranes interact to form a highly stable
‘SNARE complex’; the formation of this protein complex
is tightly coupled to membrane fusion, and indeed SNAREs
are sufficient to catalyze the fusion of lipid vesicles in vitro
[2,3]. SNARE complex assembly involves the interaction of
coiled-coil (helical) domains present in the individual
SNARE proteins to form a parallel, twisted four-helix
bundle [4–6]. Three of the helices are contributed by Q-
SNAREs present on one membrane, with the other helix
provided by an R-SNARE present on the opposing mem-
brane. The classification of SNAREs as either ‘Q’ or ‘R’
derives from the presence of a highly conserved glutamine
or arginine residue, respectively, which are located within
the core of the helical bundle [7]. In the majority of
intracellular membrane fusion pathways, the three helical
domains contributed by Q-SNAREs are present in three
distinct proteins [8]. However, in exocytic membrane fu-
sion, one Q-SNARE helix is provided by a syntaxin protein
and the other two helices are present in a single SNARE
protein, SNAP-25 [5].
SNARE complex assembly is regulated at many levels.
In neuronal and neuroendocrine cells the protein munc18-1
(also called nSec1) binds to syntaxin 1A and prevents its
interaction with its SNARE partners [9,10]. The expression
of munc18-1 is most abundant in neuronal/neuroendocrine
cells, whereas munc18-2 and munc18-3 display a more
widespread tissue distribution [11]. Munc18 proteins are
likely to be required for the controlled assembly of SNARE
complexes and are essential for membrane fusion. Other
important SNARE regulatory molecules include SNAP and
NSF, which catalyze SNARE complex disassembly follow-
ing membrane fusion [2,12,13]. In addition to these pro-
teins, a host of other factors have been shown to regulate
SNARE proteins at many levels.
This review focuses on the mechanisms and pathways
used to traffic syntaxin and SNAP-25 to the plasma mem-
brane, where these proteins exert their essential function in
exocytic membrane fusion.
1.1. Syntaxin
Members of the syntaxin family of SNARE proteins are
found on numerous intracellular organelles, and their func-
tion is required for a wide range of intracellular membrane
fusion pathways [14]. There are 15 mammalian syntaxin
genes, and four of the expressed proteins (syntaxins 1–4)are localized to the plasma membrane and function in
exocytic pathways [14]. Additionally, syntaxins 1–4 can
be expressed as alternatively spliced isoforms. These plasma
membrane syntaxins are differentially expressed in different
cell types, and can also display distinct localizations within
the plasma membrane of polarized cells. Syntaxins belong
to a family of proteins that are ‘tail-anchored’ (also called
Type IV membrane proteins); such proteins have an NH2
terminal cytoplasmic domain that is membrane-bound by
virtue of a single C-terminal hydrophobic domain and have
no ectodomain [15]. Tail-anchored proteins (unlike classical
Type II membrane proteins) are inserted posttranslationally
into membranes [15]. Depending on the length of the
hydrophobic domain and the nature of the surrounding
amino acid residues, tail-anchored proteins insert into either
the ER membrane or the mitochondrial outer membrane.
The mechanism of insertion of tail-anchored proteins into
the ER membrane can occur by a number of mechanisms
that differ in ATP dependence and receptors [15]. However,
the exact requirements for syntaxin insertion into the ER
membrane have not been analyzed. The C-terminal mem-
brane anchor of syntaxins 1–4 is preceded by a membrane
proximal f 60-amino-acid coiled-coil region that partici-
pates in SNARE complex assembly. The function of specific
syntaxin proteins is required for defined exocytosis path-
ways. For example, syntaxin 1 (which is expressed almost
exclusively in neuronal and neuroendocrine cells) functions
in exocytosis pathways such as presynaptic neurotransmitter
release [16], whereas syntaxin 4, which has a more ubiqui-
tous tissue distribution, functions in pathways such as the
exocytosis of vesicles containing the facilitative glucose
transporter, Glut4, in adipocytes [17].
1.1.1. The transmembrane domains (TMDs) of exocytic
syntaxins confer plasma membrane localization
Analysis of the membrane targeting of chimeric syntaxin
molecules has demonstrated that the TMDs are sufficient to
confer membrane binding. In Madin Darby canine kidney
(MDCK) cells, the TMDs of syntaxin 3 and syntaxin 4
target the reporter molecule GFP to the plasma membrane
[18], and the TMD of syntaxin 3 also localized GFP to the
plasma membrane in 3T3-L1 adipocytes [19]. The traffick-
ing of the syntaxin 3 TMD to the plasma membrane in
adipocytes was dependent upon its length; reducing the 25-
amino-acid TMD to a 17-amino-acid sequence caused its
accumulation in the Golgi [19]. The length of the TMD of
the yeast syntaxin homologue Sso1p also plays a prominent
role in the plasma membrane targeting of this exocytic
SNARE protein [20]. In addition, it appears that distinct
syntaxin TMDs may contain specific targeting information:
syntaxin 3 TMD targeted GFP to the apical plasma mem-
brane in MDCK cells, whereas the syntaxin 4 TMD resulted
in a predominantly basolateral distribution of GFP [18].
The plasma membrane appears to be the ‘default’ desti-
nation for a number of syntaxin proteins in the absence of
cytoplasmic domain internalization signals. In PC12 cells (a
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cytoplasmic domain of syntaxin 1A fused to the TMD of the
endosomal/TGN syntaxin 6, 7 and 8 isoforms accumulated
at the plasma membrane [21]. In contrast, when the cyto-
plasmic domains of syntaxin 6, 7 or 8 were fused to the
TMD of syntaxin 1A, the proteins were correctly localised
to endosomal/TGN membranes in rat liver Clone 9 cells
[21], suggesting that cytoplasmic sequences are required to
direct syntaxin isoforms from the plasma membrane to their
correct intracellular location.
1.1.2. Role of munc18 proteins in intracellular trafficking of
syntaxin
Several studies have found that when syntaxin 1A (a
neuronal-specific syntaxin isoform) is heterologously
expressed in nonneuronal or neurosecretion-incompetent
cells, the protein is retained intracellularly in the ER/Golgi
[21–24]. Domain swapping experiments have indicated that
this intracellular accumulation is dependent upon the cyto-
plasmic domain of syntaxin 1A [21]. Interestingly, co-
expression of munc18-1 (the neuronal isoform of munc18)
with syntaxin 1A relieves the intracellular block and leads to
plasma membrane targeting [22]. At early time points
following co-transfection, syntaxin 1A and munc18-1 co-
localize in the Golgi region of the cell, suggesting that the
two proteins traffic as a complex to the cell surface [22].
The precise role of munc18-1 in the membrane targeting of
newly synthesized syntaxin 1A is not clear, but intracellular
accumulation of syntaxin 1A in nonneuronal cells in theFig. 1. Intracellular trafficking of exocytic syntaxin and SNAP-25 proteins. The p
conformational state. In an open conformation, syntaxin is retained in the ER/Golgi
present within these compartments (a); munc18 may stabilize the closed conformat
targeting (b); syntaxin isoforms that favour a closed conformation (such as the yea
the plasma membrane (c). Plasma membrane targeting of SNAP-25 is also influ
plasma membrane (d), however, the trafficking of SNAP-25 may depend upon oth
25 accumulates intracellularly, probably as a result of its association with ER/Golg
25 may facilitate the plasma membrane trafficking of syntaxin and SNAP-25. It is
membrane would allow SNAP-25 transit to the cell surface by preventing its accabsence of munc18-1 may be a result of its interaction with
SNARE proteins in the early secretory pathway [22].
Another possibility is that the plasma membrane targeting
of syntaxin 1A requires its interaction with cholesterol-rich
lipid rafts [23,24]. Munc18-1 has been suggested to facili-
tate the interaction of syntaxin 1A with such domains [23].
Syntaxin 1A exists in at least two distinct conformations:
in an ‘open’ conformation syntaxin 1A is able to form
functional SNARE complexes, whereas munc18-1 holds
syntaxin 1A in a SNARE complex-incompatible ‘closed’
conformation [25]. Thus, munc18-1 may facilitate the
correct intracellular trafficking of syntaxin 1A by stabilizing
it in a protected conformation that prevents its participation
in unfavourable SNARE complexes [22]. The dependence
of syntaxin 1A on munc18-1 is further highlighted by
studies showing that munc18-1 null mutants have a signif-
icant reduction in cellular syntaxin 1A levels [26].
In contrast to the intracellular accumulation of syntaxin
1A, syntaxin 3 and the yeast syntaxin homologue, Sso2p,
were localized correctly to the plasma membrane when
expressed in these same cells [22,27]. Does this imply that
the dependence on munc18 for plasma membrane targeting
is specific for syntaxin 1A? Although this may be the case,
it is also possible that all mammalian plasma membrane
syntaxins require munc18 proteins for correct intracellular
trafficking; the nonneuronal cell types employed in these
studies may express abundant levels of other munc18 iso-
forms which facilitate the correct targeting of nonneuronal
syntaxin isoforms, such as syntaxin 3. Indeed, a study inlasma membrane targeting of syntaxin is proposed to be dependent upon its
region of the cell, possibly due to its interaction with other SNARE proteins
ion of syntaxin isoforms such as syntaxin 1A, facilitating plasma membrane
st protein, Ssop) may not require munc18 proteins for efficient trafficking to
enced by other factors. When expressed alone, SNAP-25 can target to the
er, as yet unidentified, factors; when co-expressed with syntaxin 1A, SNAP-
i-localized syntaxin 1A (e); co-expression of munc18, syntaxin and SNAP-
proposed that the munc18-induced trafficking of syntaxin 1A to the plasma
umulation in the ER/Golgi (f).
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syntaxin 4 required co-expression of munc18-3 for plasma
membrane delivery [28], implying that munc18 proteins
function as trafficking chaperones for syntaxin isoforms
other than syntaxin 1A. Further work is clearly required in
this area, and RNAi approaches may be successful in
selectively reducing the levels of specific munc18 isoforms
expressed in cells; this would allow a more comprehensive
analysis of the munc18-dependence of plasma membrane
trafficking of specific syntaxin isoforms in cells where they
are endogenously expressed.
At this point, it is important to reiterate that the vast
majority of studies that have implicated munc18-1 in the
plasma membrane targeting of syntaxin 1A have been
performed on nonneuronal cell lines. Undoubtedly, cells
that do not express endogenous munc18-1 are a useful
model in which to study the role of this protein in plasma
membrane targeting of syntaxin 1A. However, there is
evidence from (perhaps) more physiologically relevant
systems that syntaxin 1A can reach the plasma membrane
independently of munc18. In C. elegans, a constitutively
open mutant of syntaxin which does not interact with UNC-
18 (C. elegans homologue of munc-18) could fully rescue
syntaxin null mutants [29]. In addition, syntaxin distribution
was identical in wild-type and unc-18 null mutant C.
elegans, although syntaxin levels were reduced by 50% in
the mutants [30]. Similarly, syntaxin was suggested to be
correctly targeted in munc18-1-deficient neurons, although
no direct quantification of syntaxin plasma membrane levels
was feasible in this study [31]. These results suggest either
that syntaxin 1A trafficking has different requirements in
neuronal and nonneuronal cells, or alternatively that neuro-
nal-specific factors other than munc18 can regulate the
intracellular trafficking of syntaxin 1A.
The potential role of munc18 proteins in syntaxin traf-
ficking in yeast appears easier to decipher than for their
mammalian counterparts. The yeast munc18 homologue,
Sec1p, has a very low affinity (if any at all) for the yeast
exocytic syntaxin homologue, Ssop, but binds specifically
to assembled ternary SNARE complexes [32]. This suggests
that Ssop must reach the plasma membrane independently
of a munc18 protein, and this is consistent with the observed
plasma membrane targeting of Sso2p in mammalian cells
[27].
1.1.3. Role of the conformational state of syntaxin proteins
in subcellular trafficking
The munc18 dependence of plasma membrane targeting
of specific syntaxin proteins may depend upon the extent to
which they exist in closed or open conformation. Whereas
Sso1p appears to exist largely in a closed conformation [33],
recent work has shown that monomeric syntaxin 1A favours
an open conformation [34]. The closed conformation of
syntaxin should prevent its interaction with SNAREs pres-
ent in the secretory pathway. Thus, plasma membrane
targeting of syntaxin proteins is probably most efficientwhen the protein is in a closed conformation, the depen-
dence on munc18 being related to the favoured conforma-
tional state of specific syntaxin proteins (Fig. 1). This model
is consistent with studies of unc-18 (C. elegans) and
munc18 (mouse) knock-out organisms, syntaxin expression
being markedly reduced in both systems [26,30]. This
reduction in syntaxin expression may indicate that traffick-
ing of syntaxin is less efficient in munc18/unc-18 deficient
organisms. Nevertheless, syntaxin does reach the plasma
membrane in these deficient cells, suggesting that syntaxin
can traffic independently (although also inefficiently) of
munc18, and there may be specific neuronal factors that
can chaperone syntaxin 1A plasma membrane trafficking in
the absence of munc18.
1.2. SNAP-25
Members of the SNAP-25 protein family contribute two
of the four alpha helices that compose exocytic SNARE
complexes. Alpha helical SNARE motifs are present at the
N- and C-termini of SNAP-25 proteins and are separated by
a central cysteine-rich membrane targeting/binding domain.
The first identified SNAP-25 proteins were termed SNAP-
25A and SNAP-25B; these isoforms are highly homolo-
gous, with only nine different amino acids [35,36]. SNAP-
25A/B exhibit a restricted expression pattern, being most
abundant in neuronal and neuroendocrine cells, and these
proteins have a specialized function in fast regulated exo-
cytosis pathways, such as synaptic vesicle exocytosis [37–
39]. Another member of the SNAP-25 protein family is
SNAP-23; this protein, which shares f 60% identity with
SNAP-25, has a ubiquitous tissue distribution [40,41].
SNAP-23 has been implicated in regulated exocytosis in
nonneuronal cell types such as adipocytes and mast cells
[42,43], and may also have a general function in constitutive
exocytosis [44]. SNAP-29 is another protein related to
SNAP-25; however, as this protein is localized in many
intracellular membranes and there is no evidence that it
functions as a regular exocytic SNARE protein, it will not
be discussed further [45–47]. SNAP-25 does not contain a
TMD and membrane targeting of this protein has been
shown to be dependent upon palmitoylation. Furthermore,
syntaxin has been suggested to be required for efficient
trafficking of SNAP-25 to the plasma membrane.
1.2.1. Palmitoylation of SNAP-25
Although members of the SNAP-25 protein family do
not contain TMDs, they are bound tightly and efficiently to
cell membranes. Association of SNAP-25 and SNAP-23
with membranes is dependent upon a central cysteine-rich
domain; this domain is palmitoylated in vivo and mutants
lacking these cysteine residues are cytosolic [48–52]. The
cysteine-rich domains of SNAP-25A and SNAP-25B each
contain four cysteine residues, although the position of one
of these cysteines is different in the two isoforms [35,36],
whereas SNAP-23 contains five cysteines in the cysteine-
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highly sensitive to even single cysteine substitutions, and
mutation of any of the four cysteine residues within the
cysteine-rich domain of SNAP-25 causes a dramatic de-
crease in palmitoylation: single cysteine mutations in the
cysteine-rich domain of SNAP-25 reduced the level of
protein palmitoylation by 58–91% in COS-7 cells depend-
ing on the specific cysteine that was mutated [53]. The
minimal domain of SNAP-25 required for efficient palmi-
toylation is a 36-amino-acid sequence containing the cyste-
ine-rich domain and the 28 amino acids that follow the
cysteines [49]. This C-terminal 28-amino-acid domain con-
tains a conserved QPARV motif that is essential for SNAP-
25 palmitoylation [49]. Palmitoylation of SNAP-25 clearly
plays an essential role in targeting to the plasma membrane
[48–52]. However, palmitoylation has also been suggested
to be required for the dynamic association of SNAP-25 with
other SNARE proteins [52], and for its enrichment at
specific domains of the plasma membrane [54].
Interestingly, the half-life of SNAP-25 palmitoylation
was shown to be shorter than the half-life of the protein,
suggesting that palmitoylation of SNAP-25 may be dynamic
[53]. This intriguing observation may present a mechanism
to regulate either the membrane association of SNAP-25 or
its interaction with specific membrane subdomains.
1.2.2. Mechanism and location of SNAP-25 palmitoylation
SNAP-25 can be palmitoylated in vitro in the absence
of a palmitoylacyl transferase (PAT) enzyme; this sponta-
neous palmitoylation of SNAP-25 is markedly enhanced in
the presence of syntaxin 1 [55]. This suggests that palmi-
toylation of SNAP-25 in vivo may also occur by a non-
catalytic mechanism. However, if this were the case, then it
is more difficult to explain the effects of single cysteine
substitutions on SNAP-25 global palmitoylation, and this
may indicate that palmitoylation of SNAP-25 in vivo
requires a specific palmitoyl acyl transferase (PAT). Al-
though there are no common consensus sequences identi-
fied for protein S-palmitoylation, the position of the
cysteines and other amino acid residues in the 36 amino
acid cysteine-rich domain may form a specific site required
for palmitoylation of SNAP-25.
PAT activity has been detected at various locations within
the cell, including the plasma membrane, Golgi and ER
[56–58]. The cellular site of SNAP-25 palmitoylation is
unknown; however, palmitoylation is dependent upon a
functional secretory pathway, suggesting that SNAP-25
must enter this pathway to get palmitoylated [59]. Similarly,
palmitoylation of H-ras also requires transport through the
secretory pathway [60,61]. However, whereas disruption of
the secretory pathway by Brefeldin A (BFA, a drug that
blocks transport through the Golgi) treatment abolished
SNAP-25 palmitoylation, this drug did not prevent the
palmitoylation of H-ras [61]. These results imply that the
cellular location of SNAP-25 palmitoylation is distinct from
that of H-ras, and emphasizes that there are several PATactivities within the cell having specific substrate preferen-
ces. In yeast, Ras2p is palmitoylated by a PAT located in the
ER [58,62] and this may be similar for the mammalian ras
isoforms.
Inhibition of SNAP-25 palmitoylation by BFA therefore
implies that SNAP-25 is palmitoylated in a post-ER
compartment, presumably either the Golgi or plasma
membrane. Alternatively, the effects of BFA on SNAP-
25 palmitoylation may be indirect: SNAP-25 palmitoyla-
tion may require another protein that traffics through the
secretory pathway [59]. Identification of the subcellular
location of SNAP-25 palmitoylation could be further
probed by analyzing SNAP-25 palmitoylation at 19 jC,
a temperature that blocks protein exit from the TGN; lack
of SNAP-25 palmitoylation at this low temperature would
imply that the protein is palmitoylated at the cell surface.
The plasma membrane is enriched in PAT activity against
other palmitoylated proteins, such as G protein alpha
subunits [63]. Furthermore, this PAT activity was enriched
in cholesterol-rich microdomains of the plasma membrane
called ‘lipid rafts’ [64]. Interestingly, SNAP-25 and SNAP-
23 associate with lipid raft domains in a variety of cell
types [65–69], suggesting the possibility that this associ-
ation may be important for palmitoylation of SNAP-25 by
a specific raft-associated PAT. In this regard, it would be
interesting to examine whether disruption of lipid rafts
(through cholesterol depletion) affects SNAP-25 palmitoy-
lation. It would also be interesting to determine the role
played by lipid rafts in the surface delivery of SNAP-25
and SNAP-23.
1.2.3. Role of syntaxin in SNAP-25 membrane interactions
Palmitoylation of SNAP-25 undoubtedly performs an
essential function in the membrane targeting and binding
of these proteins. Nevertheless, SNAP-25 is not displaced
from the plasma membrane by chemical deacylation [59],
implying that palmitoylation of SNAP-25 is not required for
stable membrane association. Continued binding of SNAP-
25 to membranes following depalmitoylation suggests that
this protein may remain membrane-bound as a result of a
tight association with another protein or lipid. In agreement
with this idea, the SNAP-25 homologue of yeast, Sec9p, is
abundant at the plasma membrane in the absence of either a
TMD or lipid anchor [70].
An obvious possibility is that SNAP-25 is membrane-
bound through an interaction with its t-SNARE partner,
syntaxin 1. However, the extent of SNAP-25 association
with syntaxin 1 at steady state is unclear. In adrenal
chromaffin cells, syntaxin 1 and SNAP-25 co-cluster exten-
sively at specific sites of the plasma membrane. Disruption
of SNAP-25 binding to syntaxin leads to a loss of co-
localization and SNAP-25 is partially redistributed to the
cytosol [71]. Similarly, most SNAP-25 in primary neurons
is complexed with syntaxin 1A [72]. In contrast, SNAP-25
and syntaxin 1 in PC12 cells display only a limited co-
clustering at the plasma membrane [73], and most SNAP-25
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ingly, deacylation of SNAP-25 in PC12 cells does not
displace it from membranes suggesting, in this cell type at
least, factors other than syntaxin may facilitate SNAP-25
membrane association.
As with studies on syntaxin and munc18 (Section 1), the
specific dependence of SNAP-25 trafficking on syntaxin is
difficult to assess in cells endogenously expressing both of
these proteins. As a result, a number of investigators have
analyzed membrane targeting of these SNARE proteins in
nonneuronal cell lines that do not express endogenous
syntaxin 1 or SNAP-25. These studies clearly demonstrate
that syntaxin affects the membrane targeting of newly
synthesized SNAP-25. When expressed in HeLa cells,
newly synthesized SNAP-25 associates inefficiently with
cell membranes; however, co-expression of syntaxin 1
markedly increases the binding of newly synthesized
SNAP-25 to membranes [75]. Furthermore, a normally
cytosolic SNAP-25 mutant lacking the palmitoylation do-
main was efficiently targeted to membranes when co-
expressed with syntaxin 1 [75]. Analysis of SNAP-25
membrane targeting in BHK and COS7 cells also suggests
that syntaxin functions in trafficking of newly synthesized
SNAP-25 [52]. In these cells, SNAP-25 accumulates at the
plasma membrane when expressed alone, whereas syntaxin
is targeted to the Golgi region. However, co-expression of
syntaxin 1 and SNAP-25 leads to accumulation of SNAP-25
in the Golgi region of the cells. In addition, syntaxin 1 co-
expression targeted normally cytosolic mutants of SNAP-25
to this intracellular compartment. Syntaxin 1 has also been
shown to partially restore membrane localization of SNAP-
25 cysteine mutants in pancreatic beta cells [76]. The
dominant effect of syntaxin on SNAP-25 intracellular dis-
tribution was further emphasized when wild-type SNAP-25
was co-expressed with a syntaxin mutant lacking the TMD:
this resulted in SNAP-25 remaining in the cytosol along
with mutant syntaxin. These results suggest the possibility
that syntaxin 1 functions as a molecular chaperone for
SNAP-25, mediating its initial targeting to membranes,
and hence facilitating its subsequent palmitoylation [75].
Indeed, newly synthesized SNAP-25 has been detected
associated with syntaxin 1 in the cytosol [75].
Nevertheless, there are a number of inconsistencies with
a model in which syntaxin 1 directs SNAP-25’s intracel-
lular traffic. In particular, a 36-amino-acid membrane
binding domain of SNAP-25 (residues 85–120, which
include the palmitoylation site, but not the syntaxin bind-
ing site) has been shown to target GFP to the plasma
membrane in neuronal cell types [49]. Additionally, a
SNAP-25 protein with a single point mutation that abol-
ished binding to syntaxin was also correctly targeted to the
plasma membrane in neuronal cells [51]. These results
suggest that in cells endogenously expressing SNAP-25 the
membrane targeting of this protein is independent of
syntaxin. Nonneuronal cells may lack a specific factor
required for the membrane targeting or palmitoylation ofSNAP-25 [51]. Another concern with this model of SNAP-
25 plasma membrane trafficking relates to the relative
expression levels of syntaxin and SNAP-25. Quantification
of SNAP-25/syntaxin1 levels in synaptosomes [77], cere-
bellar neurons [72], PC12 cells [72] and SNAP-23/syntaxin
4 levels in adipocytes [78] demonstrated that SNAP-25/23
were present at greater levels than their syntaxin counter-
part. Although the expression levels of SNAP-25 were
only slightly greater than syntaxin in synaptosomes and
cerebellar neurons, SNAP-25 was expressed at five- to
sixfold higher levels than syntaxin in PC12 cells [72], and
SNAP-23 was expressed at threefold higher levels than
syntaxin 4 in adipocytes [78]. As the half-life of SNAP-25
is shorter than syntaxin [53,75,79], these observations
suggest that at steady state there will be a significant (or
substantial) excess of SNAP-25 synthesized relative to
syntaxin. Furthermore, SNAP-25 is efficiently targeted to
the plasma membrane even when overexpressed in neuro-
nal/neuroendocrine cells, which may increase the ratio of
SNAP-25/syntaxin by several orders of magnitude (Ref.
[51]; authors’ unpublished observation). These observa-
tions suggest that unless syntaxin 1A recycles from the
plasma membrane to the cytosol, syntaxin 1A is unlikely to
be present at sufficient levels to support membrane target-
ing of newly synthesized SNAP-25.
1.2.4. A model for SNAP-25 trafficking and membrane
association
Studies on SNAP-25 membrane trafficking in neuronal/
neuroendocrine cells (i.e. cells that normally express SNAP-
25) demonstrate that interaction with syntaxin is not re-
quired for either palmitoylation or plasma membrane local-
ization of SNAP-25 [49,51]. In nonneuronal cell lines,
syntaxin expression can interfere with the plasma membrane
binding of SNAP-25 and can also drive the membrane
association of cysteine-less SNAP-25 mutants [52]. How-
ever, in these cell types syntaxin is not correctly targeted; it
accumulates in the Golgi region rather than at the plasma
membrane. Thus, it is likely that Golgi-localized syntaxin
1A can interact with SNAP-25 during its transport through
the secretory pathway, and retain SNAP-25 at this intracel-
lular location. Interestingly, when syntaxin 1A is expressed
in MDCK cells it accumulates on lysosomal membranes
[80]; at this cellular location syntaxin 1A is unable to
interfere with SNAP-25 trafficking, which targets efficiently
to the plasma membrane in the presence or absence of
syntaxin co-expression [81]. A further point of note is that
(as discussed in Section 1.2) syntaxin 1A requires co-
expression of munc18-1 for effective plasma membrane
localization and protein stability [22–24,26]. Munc18-1
binding to syntaxin 1A holds syntaxin in a closed confor-
mation; in this conformation syntaxin is unable to bind to
SNAP-25. Thus, under normal conditions the requirement
of syntaxin 1 to bind munc18-1 for plasma membrane
targeting should prevent the interaction of newly synthe-
sized syntaxin with SNAP-25 (Fig. 1).
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fication of the membrane-bound factors that allow the
continued association of SNAP-25 with the plasma mem-
brane following chemical depalmitoylation [59]. Clues to
this question are likely to come from further analysis
of membrane targeting and binding of the SNAP-25(85–
120)-GFP chimera; for example, does this chimera remain
membrane-bound following chemical depalmitoylation?
Additionally, as SNAP-25 only becomes palmitoylated
during or after transport through the secretory pathway
[59], there must be other targeting information present
within the protein sequence that serves to direct newly syn-
thesized SNAP-25 to the secretory pathway. It is known
that prenylation of H- and N-ras target these proteins to
the secretory pathway, however, SNAP-25 does not con-
tain a consensus site for such modification; so what directs
it to the secretory pathway? Finally, it is formally possible
that SNAP-25 does not traffic through the secretory
pathway and that the effects of BFA on SNAP-25 stabil-
ity/palmitoylation/targeting reflect the requirement for an-
other protein that does traffic through the secretory
pathway [59].2. Concluding remarks and future perspective
If indeed SNARE proteins are membrane fusion cata-
lysts, then it is sensible to assume that their intracellular
trafficking is tightly regulated, and that the proteins are
transported in an ‘inactive’ form. Undoubtedly, the con-
trolled conversion of syntaxin proteins from an open to a
closed conformation is key to their cellular functions;
however, the conformational state of syntaxins is also
likely to impact on their intracellular trafficking. Syntaxin
proteins are likely to be chaperoned during their transport
within the cell. In cases such as the yeast syntaxin, Ssop,
the N-terminal domain of the protein that folds over the
SNARE-binding domain would make the protein function-
ally impotent and hence facilitate plasma membrane target-
ing, by acting as an intramolecular chaperone. However,
for syntaxin proteins that favour an open conformation,
there is likely to be a requirement for other factors which
either stabilize the closed conformation (munc18) or that
shield the SNARE binding domain. Similar factors may
also be required for SNAP-25 trafficking to the plasma
membrane; however, the proposal that syntaxin trafficking
depends upon a closed conformation would rule out this
protein as a SNAP-25 chaperone. In addition, it appears
unlikely that cells would transport a functional Q-SNARE
complex (with affinity for R-SNAREs) through various
membranes of the secretory pathway. Clearly, there are
many more questions than answers, but the development of
techniques that permit the simple ‘knock-down’ of specific
cellular proteins will be a useful tool to dissect the precise
molecular mechanisms involved in the plasma membrane
targeting of exocytic SNAREs.Acknowledgements
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